AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 8598837 — intervention group
Group type: EXPERIMENTAL
Intervention: Induction of labor with vaginal prostaglandin E2 gel
Number of subjects: 5041
Study 8598837 — intervention group
Group type: COMPARATOR
Intervention: Expectant management (oxytocin)
Number of subjects: 5041
Study 8598837 — intervention group
Group type: COMPARATOR
Intervention: Expectant management (prostaglandin)
Number of subjects: 5041
Study 2058572 — intervention group
Group type: EXPERIMENTAL
Intervention: n-3 polyunsaturated fatty acids (PUFAs)
Number of subjects: 36
Study 2058572 — intervention group
Group type: COMPARATOR
Intervention: Control diet (without fish-oil supplement)
Number of subjects: 36
Study 6337322 — intervention group
Group type: EXPERIMENTAL
Intervention: Decongestant-antihistamine combination (pseudoephedrine hydrochloride, 4 mg/kg/day and chlorpheniramine maleate, 0.35 mg/kg/day)
Number of subjects: 553
Study 6337322 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 553
Study 6337322 — intervention group
Group type: EXPERIMENTAL
Intervention: Decongestant-antihistamine combination
Number of subjects: 553
Study 31707107 — intervention group
Group type: EXPERIMENTAL
Intervention: Sensorimotor rhythm (SMR) NFB (n = 15)
Number of subjects: 44
Study 31707107 — intervention group
Group type: EXPERIMENTAL
Intervention: Slow cortical potentials (SCP) NFB (n = 16)
Number of subjects: 44
Study 31707107 — intervention group
Group type: COMPARATOR
Intervention: Sham NFB (n = 13)
Number of subjects: 44
Study 29886635 — intervention group
Group type: EXPERIMENTAL
Intervention: Simplified drilling method (guided drill + final drill)
Number of subjects: 46
Study 29886635 — intervention group
Group type: COMPARATOR
Intervention: Conventional drilling method (step by step drill)
Number of subjects: 46
Study 29886635 — intervention group
Group type: EXPERIMENTAL
Intervention: Simplified drilling method
Number of subjects: 46
Study 29886635 — intervention group
Group type: COMPARATOR
Intervention: Conventional drilling method
Number of subjects: 46
Study 27411268 — intervention group
Group type: EXPERIMENTAL
Intervention: Tourniquet group
Number of subjects: 168
Study 27411268 — intervention group
Group type: COMPARATOR
Intervention: Non-tourniquet group
Number of subjects: 168
Study 24360612 — intervention group
Group type: EXPERIMENTAL
Intervention: Azacitidine
Number of subjects: 0
Study 24360612 — intervention group
Group type: COMPARATOR
Intervention: Conventional Care Regimens (CCR)
Number of subjects: 0
Study 22842212 — intervention group
Group type: EXPERIMENTAL
Intervention: Single oral dose of citalopram
Number of subjects: 12
Study 22842212 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 19800816 — intervention group
Group type: EXPERIMENTAL
Intervention: Esmolol
Number of subjects: 1765
Study 19800816 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 1765
Study 18001404 — intervention group
Group type: EXPERIMENTAL
Intervention: 10-day moxifloxacin-based triple therapy (moxifloxacin 400 mg q.d., amoxicillin 1000 mg b.i.d., esomeprazole 20 mg b.i.d.)
Number of subjects: 192
Study 18001404 — intervention group
Group type: COMPARATOR
Intervention: 2-week quadruple therapy (esomeprazole 20 mg b.i.d., tripotassium dicitrate bismuthate 300 mg q.i.d., metronidazole 500 mg t.i.d., tetracycline 500 mg q.i.d.)
Number of subjects: 192
Study 15698450 — intervention group
Group type: EXPERIMENTAL
Intervention: CAPD with a target creatinine clearance >/=60 L/week/1.73 m(2)
Number of subjects: 0
Study 15698450 — intervention group
Group type: COMPARATOR
Intervention: Standard 4 x 2 L continuous ambulatory peritoneal dialysis (CAPD)
Number of subjects: 0
Study 11960607 — intervention group
Group type: EXPERIMENTAL
Intervention: Complete antioxidant formula (alpha‐tocopherol, alpha‐lipoic acid, coenzyme Q(10), carnitines, selenomethionine)
Number of subjects: 20
Study 11960607 — intervention group
Group type: COMPARATOR
Intervention: Incomplete antioxidant formula (alpha‐tocopherol, alpha‐lipoic acid, coenzyme Q(10), selenomethionine)
Number of subjects: 20
Study 11960607 — intervention group
Group type: COMPARATOR
Intervention: Carnitines
Number of subjects: 20
Study 9931813 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic splitting (ERC/EPT, followed by laparoscopic cholecystectomy)
Number of subjects: 3618
Study 7653482 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent cyclic etidronate (400 mg/d for 14 days followed by calcium 500 mg/d for 76 days)
Number of subjects: 39
Study 7653482 — intervention group
Group type: COMPARATOR
Intervention: Calcium supplementation (500 mg/d)
Number of subjects: 39
Study 2510348 — intervention group
Group type: EXPERIMENTAL
Intervention: DDAVP (desamino‐d‐arginine vasopressin) intravenously
Number of subjects: 6
Study 1232529 — intervention group
Group type: EXPERIMENTAL
Intervention: Melphalan and prednisone 0.6 mg/kg
Number of subjects: 0
Study 1232529 — intervention group
Group type: EXPERIMENTAL
Intervention: Melphalan and prednisone 0.3 mg/kg
Number of subjects: 0
Study 1232529 — intervention group
Group type: COMPARATOR
Intervention: Melphalan alone
Number of subjects: 0
Study 31753043 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Therapy (CT)
Number of subjects: 151
Study 31753043 — intervention group
Group type: COMPARATOR
Intervention: Interpersonal Psychotherapy (IPT)
Number of subjects: 151
Study 30119088 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study 28946577 — intervention group
Group type: EXPERIMENTAL
Intervention: Task specific training and wrist/fingers extension splint
Number of subjects: 24
Study 28946577 — intervention group
Group type: COMPARATOR
Intervention: Traditional passive stretch and range of motion exercises
Number of subjects: 24
Study 26063699 — intervention group
Group type: EXPERIMENTAL
Intervention: Triple P levels 2‐3
Number of subjects: 759
Study 26063699 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 759
Study 22897451 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline compensation use
Number of subjects: 22
Study 22897451 — intervention group
Group type: COMPARATOR
Intervention: Cognitive impairment (measured by RBANS)
Number of subjects: 22
Study 22897451 — intervention group
Group type: COMPARATOR
Intervention: Family-reported memory problems (NFI)
Number of subjects: 22
Study 20373478 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg tandospirone (TSP)
Number of subjects: 18
Study 20373478 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg diazepam (DZP)
Number of subjects: 18
Study 20373478 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PCB)
Number of subjects: 18
Study 18307248 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcoholic beverage
Number of subjects: 70
Study 18307248 — intervention group
Group type: COMPARATOR
Intervention: Placebo beverage
Number of subjects: 70
Study 16536020 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-Invasive Mechanical Ventilation (NIMV)
Number of subjects: 0
Study 16536020 — intervention group
Group type: COMPARATOR
Intervention: Oxygen-therapy with helmet
Number of subjects: 0
Study 12507212 — intervention group
Group type: EXPERIMENTAL
Intervention: Randomized Controlled Trials (RCTs)
Number of subjects: 210
Study 12507212 — intervention group
Group type: EXPERIMENTAL
Intervention: Controlled Clinical Trials (CCTs)
Number of subjects: 210
Study 12507212 — intervention group
Group type: EXPERIMENTAL
Intervention: Reports of RCTs registered in Medline
Number of subjects: 210
Study 12507212 — intervention group
Group type: EXPERIMENTAL
Intervention: Hand-searching
Number of subjects: 210
Study 12507212 — intervention group
Group type: EXPERIMENTAL
Intervention: Literature search in Medline
Number of subjects: 210
Study 10520446 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous transluminal coronary angioplasty (PTCA)
Number of subjects: 2
Study 10520446 — intervention group
Group type: COMPARATOR
Intervention: Coronary artery bypass grafting (CABG)
Number of subjects: 2
Study 7729275 — intervention group
Group type: EXPERIMENTAL
Intervention: Misoprostol coadministered with diclofenac
Number of subjects: 384
Study 7729275 — intervention group
Group type: COMPARATOR
Intervention: Placebo coadministered with diclofenac
Number of subjects: 384
Study 2325568 — intervention group
Group type: EXPERIMENTAL
Intervention: 1,25‐(OH)2D3 (calcitriol; Rocaltrol)
Number of subjects: 0
Study 2325568 — intervention group
Group type: COMPARATOR
Intervention: Matching placebo
Number of subjects: 0
Study 7024157 — intervention group
Group type: EXPERIMENTAL
Intervention: Very-low-calorie diet with exercise (1650 kcal/week, 3 times a week)
Number of subjects: 18
Study 7024157 — intervention group
Group type: COMPARATOR
Intervention: Very-low-calorie diet alone
Number of subjects: 18
Study 30181533 — intervention group
Group type: EXPERIMENTAL
Intervention: EBD combined with triamcinolone (50 mg/5 mL)
Number of subjects: 65
Study 30181533 — intervention group
Group type: COMPARATOR
Intervention: Placebo (normal saline solution)
Number of subjects: 65
Study 26497691 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine cigarettes (8.9 mg)
Number of subjects: 96
Study 26497691 — intervention group
Group type: COMPARATOR
Intervention: Placebo cigarettes (1.0 mg)
Number of subjects: 96
Study 24835579 — intervention group
Group type: EXPERIMENTAL
Intervention: Twin intervention (TI) group
Number of subjects: 162
Study 24835579 — intervention group
Group type: COMPARATOR
Intervention: Twin control (TC) group
Number of subjects: 162
Study 22348801 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual Reality (VR)
Number of subjects: 41
Study 22348801 — intervention group
Group type: COMPARATOR
Intervention: Standard distraction
Number of subjects: 41
Study 21112427 — intervention group
Group type: EXPERIMENTAL
Intervention: Anterior AFO
Number of subjects: 14
Study 21112427 — intervention group
Group type: EXPERIMENTAL
Intervention: Posterior AFO
Number of subjects: 14
Study 21112427 — intervention group
Group type: COMPARATOR
Intervention: No AFO
Number of subjects: 14
Study 18772208 — intervention group
Group type: EXPERIMENTAL
Intervention: Case conferences between GPs and specialist palliative care services
Number of subjects: 0
Study 18772208 — intervention group
Group type: COMPARATOR
Intervention: Usual care and communication methods
Number of subjects: 0
Study 15871316 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 U botulinum toxin type A
Number of subjects: 80
Study 15871316 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 U botulinum toxin type A
Number of subjects: 80
Study 15871316 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 U botulinum toxin type A
Number of subjects: 80
Study 15871316 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 U botulinum toxin type A
Number of subjects: 80
Study 15871316 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 U botulinum toxin type A (open-label extension)
Number of subjects: 80
Study 12799115 — intervention group
Group type: EXPERIMENTAL
Intervention: Listerine (pH 3.87, F(-) 0.021 ppm)
Number of subjects: 48
Study 12799115 — intervention group
Group type: EXPERIMENTAL
Intervention: Corsodyl (pH 5.65, F(-) 0 ppm)
Number of subjects: 48
Study 12799115 — intervention group
Group type: EXPERIMENTAL
Intervention: Tesco Value (pH 6.05, F(-) 289.00 ppm)
Number of subjects: 48
Study 12799115 — intervention group
Group type: EXPERIMENTAL
Intervention: Tesco Total Care (pH 6.20, F(-) 313.84 ppm)
Number of subjects: 48
Study 12799115 — intervention group
Group type: EXPERIMENTAL
Intervention: Sainsbury's (pH 6.15, F(-) 365.75 ppm)
Number of subjects: 48
Study 12799115 — intervention group
Group type: EXPERIMENTAL
Intervention: Sensodyne (pH 6.12, F(-) 285.30 ppm)
Number of subjects: 48
Study 12799115 — intervention group
Group type: COMPARATOR
Intervention: Positive control (citric acid, pH 2.7, F(-) 0 ppm)
Number of subjects: 48
Study 12799115 — intervention group
Group type: COMPARATOR
Intervention: Negative control (pH 7.0, F(-) 0 ppm)
Number of subjects: 48
Study 10470633 — intervention group
Group type: EXPERIMENTAL
Intervention: Tramadol (150 mg bolus + 250 mg infusion over 3 hours)
Number of subjects: 8
Study 10470633 — intervention group
Group type: EXPERIMENTAL
Intervention: Meperidine (112.5 mg bolus + 187.5 mg infusion over 3 hours)
Number of subjects: 8
Study 10470633 — intervention group
Group type: EXPERIMENTAL
Intervention: Tramadol
Number of subjects: 8
Study 8609263 — intervention group
Group type: EXPERIMENTAL
Intervention: Adapalene gel 0.1%
Number of subjects: 323
Study 8609263 — intervention group
Group type: COMPARATOR
Intervention: Tretinoin gel 0.025%
Number of subjects: 323
Study 1936478 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 60
Study 1936478 — intervention group
Group type: COMPARATOR
Intervention: Gliclazide
Number of subjects: 60
Study 7035441 — intervention group
Group type: EXPERIMENTAL
Intervention: Pimozide
Number of subjects: 43
Study 7035441 — intervention group
Group type: COMPARATOR
Intervention: Chlorpromazine
Number of subjects: 43
Study 30701467 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 mg thalidomide maintenance (Group B)
Number of subjects: 34
Study 30701467 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mg thalidomide maintenance (Group C)
Number of subjects: 34
Study 30701467 — intervention group
Group type: COMPARATOR
Intervention: No maintenance (Group A)
Number of subjects: 34
Study 28681218 — intervention group
Group type: EXPERIMENTAL
Intervention: Cisplatin (75 mg/m2, day 1) with paclitaxel (80 mg/m2, days 1, 8, and 15) every 21 days as neoadjuvant chemotherapy (NAC) for 3 cycles before radical hysterectomy (RH).
Number of subjects: 63
Study 28681218 — intervention group
Group type: EXPERIMENTAL
Intervention: Cisplatin plus dose-dense paclitaxel (dose-dense TP) for 3 cycles before and 2 cycles after radical hysterectomy (RH).
Number of subjects: 63
Study 26920745 — intervention group
Group type: EXPERIMENTAL
Intervention: Workplace mental health intervention (multi-session leadership coaching and tailored mental health literacy training)
Number of subjects: 240
Study 26920745 — intervention group
Group type: COMPARATOR
Intervention: Usual care control condition
Number of subjects: 240
Study 26920745 — intervention group
Group type: EXPERIMENTAL
Intervention: Workplace mental health intervention
Number of subjects: 240
Study 24720402 — intervention group
Group type: EXPERIMENTAL
Intervention: Bixalomer (1.5 g/day adjusted to a maximum of 7.5 g/day)
Number of subjects: 110
Study 24720402 — intervention group
Group type: COMPARATOR
Intervention: Sevelamer hydrochloride (3.0 or 6.0 g/day adjusted to a maximum of 9.0 g/day)
Number of subjects: 110
Study 24720402 — intervention group
Group type: EXPERIMENTAL
Intervention: Bixalomer
Number of subjects: 110
Study 22929118 — intervention group
Group type: EXPERIMENTAL
Intervention: Fish oil (FO) supplementation for twelve weeks
Number of subjects: 0
Study 22929118 — intervention group
Group type: COMPARATOR
Intervention: Corn oil supplementation for twelve weeks
Number of subjects: 0
Study 18945653 — intervention group
Group type: EXPERIMENTAL
Intervention: Half elemental diet (ED)
Number of subjects: 51
Study 18945653 — intervention group
Group type: COMPARATOR
Intervention: Free diet
Number of subjects: 51
Study 17200765 — intervention group
Group type: EXPERIMENTAL
Intervention: EE‐EC (estrogen and levonorgestrel)
Number of subjects: 11
Study 17200765 — intervention group
Group type: EXPERIMENTAL
Intervention: LNG‐EC (levonorgestrel only)
Number of subjects: 11
Study 17200765 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 11
Study 16083710 — intervention group
Group type: COMPARATOR
Intervention: lamivudine 100 mg/day
Number of subjects: 104
Study 16083710 — intervention group
Group type: EXPERIMENTAL
Intervention: telbivudine 400 mg/day
Number of subjects: 104
Study 16083710 — intervention group
Group type: EXPERIMENTAL
Intervention: telbivudine 600 mg/day
Number of subjects: 104
Study 16083710 — intervention group
Group type: EXPERIMENTAL
Intervention: Comb400 (telbivudine 400 mg/day + lamivudine 100 mg/day)
Number of subjects: 104
Study 16083710 — intervention group
Group type: EXPERIMENTAL
Intervention: Comb600 (telbivudine 600 mg/day + lamivudine 100 mg/day)
Number of subjects: 104
Study 12569811 — intervention group
Group type: EXPERIMENTAL
Intervention: Decalcified dental matrix (DDM)
Number of subjects: 42
Study 12569811 — intervention group
Group type: COMPARATOR
Intervention: Control group (no DDM)
Number of subjects: 42
Study 12569811 — intervention group
Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 42
Study 10721440 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-management intervention (n = 44)
Number of subjects: 92
Study 10721440 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control (n = 48)
Number of subjects: 92
Study 7993000 — intervention group
Group type: EXPERIMENTAL
Intervention: Minocycline (200 mg/d)
Number of subjects: 219
Study 7993000 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 219
Study 1701924 — intervention group
Group type: EXPERIMENTAL
Intervention: m-BACOD (doxorubicin-containing regimen)
Number of subjects: 70
Study 1701924 — intervention group
Group type: COMPARATOR
Intervention: m-BNCOD (mitoxantrone-containing regimen)
Number of subjects: 70
Study 7011293 — intervention group
Group type: EXPERIMENTAL
Intervention: Two tablets (0.96 grams) of Co-trimoxazole twice a day for one day
Number of subjects: 48
Study 7011293 — intervention group
Group type: EXPERIMENTAL
Intervention: Four tablets (1.92 grams) of Co-trimoxazole as a single dose
Number of subjects: 48
Study 7011293 — intervention group
Group type: EXPERIMENTAL
Intervention: Two tablets of Co-trimoxazole twice a day for seven days
Number of subjects: 48
Study 30334934 — intervention group
Group type: EXPERIMENTAL
Intervention: Regional Anesthesia (RA)
Number of subjects: 100
Study 30334934 — intervention group
Group type: COMPARATOR
Intervention: General Anesthesia (GA)
Number of subjects: 100
Study 31747035 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive valence system-focused cognitive behavioral therapy with inaudible high-frequency sound
Number of subjects: 44
Study 31747035 — intervention group
Group type: COMPARATOR
Intervention: Cognitive behavioral therapy with placebo sound
Number of subjects: 44
Study 28062916 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.5 mg/kg ATG
Number of subjects: 38
Study 28062916 — intervention group
Group type: COMPARATOR
Intervention: No ATG (reference arm)
Number of subjects: 38
Study 26264417 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise
Number of subjects: 21
Study 26264417 — intervention group
Group type: COMPARATOR
Intervention: Acute smoking
Number of subjects: 21
Study 26264417 — intervention group
Group type: COMPARATOR
Intervention: Exercise followed by smoking
Number of subjects: 21
Study 26264417 — intervention group
Group type: COMPARATOR
Intervention: Rest
Number of subjects: 21
Study 26264417 — intervention group
Group type: COMPARATOR
Intervention: Nonsmokers during exercise
Number of subjects: 21
Study 26264417 — intervention group
Group type: EXPERIMENTAL
Intervention: Smokers during exercise
Number of subjects: 21
Study 23399350 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypertensive pregnancy disorders (HTP)
Number of subjects: 405
Study 22524073 — intervention group
Group type: EXPERIMENTAL
Intervention: Zinc Oxide Eugenol (ZOE)
Number of subjects: 120
Study 22524073 — intervention group
Group type: COMPARATOR
Intervention: Zinc Polycarboxylate (ZPC)
Number of subjects: 120
Study 20449933 — intervention group
Group type: EXPERIMENTAL
Intervention: Prednisone
Number of subjects: 84
Study 18001454 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoloop
Number of subjects: 102
Study 15033248 — intervention group
Group type: EXPERIMENTAL
Intervention: Ischaemic rest pain (IRP)
Number of subjects: 80
Study 15033248 — intervention group
Group type: COMPARATOR
Intervention: Intermittent claudication (IC)
Number of subjects: 80
Study 15033248 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 80
Study 15033248 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute myocardial infarction (AMI)
Number of subjects: 80
Study 15033248 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 80
Study 11244376 — intervention group
Group type: EXPERIMENTAL
Intervention: Serotonin reuptake inhibitors (SRIs)
Number of subjects: 93
Study 9738752 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative intravenous antibiotics followed by oral antibiotics for 5 days after surgery
Number of subjects: 146
Study 9738752 — intervention group
Group type: COMPARATOR
Intervention: No prophylactic antibiotics (control group)
Number of subjects: 146
Study 11271328 — intervention group
Group type: EXPERIMENTAL
Intervention: FK 506
Number of subjects: 17
Study 11271328 — intervention group
Group type: COMPARATOR
Intervention: cyclosporin A
Number of subjects: 17
Study 2470995 — intervention group
Group type: EXPERIMENTAL
Intervention: Isradipine 15 mg/day
Number of subjects: 203
Study 2470995 — intervention group
Group type: EXPERIMENTAL
Intervention: Isradipine (various doses: 0, 2.5, 5, 7.5, or 10 mg twice daily)
Number of subjects: 203
Study 2470995 — intervention group
Group type: EXPERIMENTAL
Intervention: Isradipine
Number of subjects: 203
Study 15725154 — intervention group
Group type: EXPERIMENTAL
Intervention: Obese individuals (Group I)
Number of subjects: 122
Study 15725154 — intervention group
Group type: COMPARATOR
Intervention: Overweight individuals (Group II)
Number of subjects: 122
Study 15725154 — intervention group
Group type: COMPARATOR
Intervention: Normal BMI individuals (Group III)
Number of subjects: 122
Study 31667490 — intervention group
Group type: EXPERIMENTAL
Intervention: Cash transfer conditional on school attendance
Number of subjects: 0
Study 31667490 — intervention group
Group type: EXPERIMENTAL
Intervention: Parental monitoring and involvement
Number of subjects: 0
Study 31667490 — intervention group
Group type: EXPERIMENTAL
Intervention: Reporting a partner would hit her if she asked him to wear a condom
Number of subjects: 0
Study 31667490 — intervention group
Group type: EXPERIMENTAL
Intervention: All mediators jointly
Number of subjects: 0
Study 31185118 — intervention group
Group type: EXPERIMENTAL
Intervention: Midline lumbar fusion (MidLIF) with cortical bone trajectory (CBT) screw fixation
Number of subjects: 70
Study 31185118 — intervention group
Group type: COMPARATOR
Intervention: Transforaminal lumbar interbody fusion (TLIF) using traditional pedicle screw (TPS) fixation
Number of subjects: 70
Study 29217019 — intervention group
Group type: EXPERIMENTAL
Intervention: Mozart music (sonata for 2 pianos in D-K448)
Number of subjects: 26
Study 29217019 — intervention group
Group type: COMPARATOR
Intervention: Silence (control group)
Number of subjects: 26
Study 26300367 — intervention group
Group type: EXPERIMENTAL
Intervention: Smoking hygiene intervention delivered by trained community health workers
Number of subjects: 318
Study 26300367 — intervention group
Group type: COMPARATOR
Intervention: Control group (comparison group)
Number of subjects: 318
Study 23316787 — intervention group
Group type: EXPERIMENTAL
Intervention: Coaching
Number of subjects: 201